Flexion Therapeutics
FLXN
$9.12
Share price
0.00%
Change (1 day)
8,190.91%
Change (1 year)
Categories
Revenue for Flexion Therapeutics (FLXN)
Revenue in 2021 (TTM): $0.10 B
According to Flexion Therapeutics 's latest financial reports the company's current revenue (TTM) is $0.10 B. In 2020 the company made a revenue of $85.55 M an increase over the years 2019 revenue that were of $72.95 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Flexion Therapeutics from 2018 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | $0.10 B | 17.36% |
| 2020 | $85.55 M | 17.26% |
| 2019 | $72.95 M | 223.91% |
| 2018 | $22.52 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 92,551.39% | 🇺🇸 USA |
 Pfizer PFE | $58.49 B | 58,163.94% | 🇺🇸 USA |
 Recro Pharma
REPH | $75.36 M | -24.94% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $0.67 B | 572.29% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $0.65 M | -99.35% | 🇺🇸 USA |
 Ampio Pharmaceuticals AMPE | N/A | N/A | 🇺🇸 USA |
 Cara Therapeutics
CARA | $20.96 M | -79.12% | 🇺🇸 USA |